Literature DB >> 15074181

[Dientamoeba fragilis: possibly an important cause of persistent abdominal pain in children].

D K Bosman1, M A Benninga, P van de Berg, G C Kooijman, T van Gool.   

Abstract

OBJECTIVE: To determine the effect of an antiprotozoic treatment on children with persistent abdominal pain and infection with Dientamoeba fragilis.
DESIGN: Retrospective.
METHOD: A total of 43 children with D. fragilis infection and persistent gastrointestinal complaints were included in the study. Of these 27 were treated with clioquinol and 16 with a nitroimidazole drug: metronidazole or tinidazole. The parasitological and clinical effects of the treatment were assessed.
RESULTS: In 33 of the 43 (77%) children, no parasites were detected during follow-up with a triple faeces test: 22/27 following treatment with clioquinol and 11/16 following treatment with a nitroimidazole drug. In 27 of the 33 (82%) children with a negative follow-up result, gastrointestinal complaints were considerably less or had completely disappeared. In 2 of the 10 (20%) children in which D. fragilis had not disappeared in the follow-up period, the complaints were less or had disappeared.
CONCLUSION: Effective treatment of D. fragilis infection in children with longstanding gastrointestinal complaints often resulted in a reduction or disappearance of the complaints.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15074181

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  7 in total

1.  A review of the clinical presentation of dientamoebiasis.

Authors:  Damien Stark; Joel Barratt; Tamalee Roberts; Deborah Marriott; John Harkness; John Ellis
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

2.  History of antimicrobial use and the risk of Dientamoeba fragilis infection.

Authors:  D Röser; J Simonsen; H V Nielsen; C R Stensvold; K Mølbak
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-02-07       Impact factor: 3.267

Review 3.  Molecular testing for clinical diagnosis and epidemiological investigations of intestinal parasitic infections.

Authors:  Jaco J Verweij; C Rune Stensvold
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

Review 4.  Dientamoeba fragilis, the Neglected Trichomonad of the Human Bowel.

Authors:  Damien Stark; Joel Barratt; Douglas Chan; John T Ellis
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

5.  Treatment of Dientamoeba fragilis in patients with irritable bowel syndrome.

Authors:  Anne Line Engsbro; C Rune Stensvold; Henrik V Nielsen; Peter Bytzer
Journal:  Am J Trop Med Hyg       Date:  2012-10-22       Impact factor: 2.345

6.  Is paromomycin the drug of choice for eradication of Dientamoeba fragilis in adults?

Authors:  Jaap J van Hellemond; Nicky Molhoek; Rob Koelewijn; Pieter J Wismans; Perry J J van Genderen
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-04-14       Impact factor: 4.077

Review 7.  Current treatment options for Dientamoeba fragilis infections.

Authors:  Noriyuki Nagata; Deborah Marriott; John Harkness; John T Ellis; Damien Stark
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-09-03       Impact factor: 4.077

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.